Genetics of parkinsonism: A review

Annals of Human Genetics

Volumn 65, Issue 2, 2001, Pages 111-126

  Vaughan, J R ^a   Davis, M B ^a   Wood, N W ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; CELL PROTEIN; HYDROLASE; PARKIN; UBIQUITIN; UNCLASSIFIED DRUG;

ARTICLE; CELL LOSS; CLINICAL FEATURE; DEGENERATIVE DISEASE; DISABILITY; DISEASE COURSE; DOPAMINERGIC NERVE CELL; ENVIRONMENTAL FACTOR; FAMILIAL DISEASE; FAMILY SIZE; GENE LOCUS; GENE MUTATION; GENETIC HETEROGENEITY; GENETICS; HEREDITY; HERITABILITY; HUMAN; LEWY BODY; MOLECULAR BIOLOGY; PARKINSON DISEASE; PARKINSONISM; PATHOGENESIS; PATHOLOGY; POPULATION; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

ALPHA-SYNUCLEIN; HUMANS; LEWY BODIES; LIGASES; NERVE TISSUE PROTEINS; PARKINSON DISEASE; SUBSTANTIA NIGRA; SYNUCLEINS; UBIQUITIN-PROTEIN LIGASES;

EID: 0035020181     PISSN: 00034800     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0003480001008557     Document Type: Article

References (120)

1. Abbas, N., Lucking, O. B., Ricard, S., Durr, A., Bonifati, V., De Michele, G., Bouley, M., Vaughan, J. R., Gasser, T., Marconi, R., Broussolle, E., Brefel-Courbon, C., Harhangi, B. S., Oostra, B. A., Fabrizio, E., Bohme, G. A., Pradier, L., Wood, N. W., Filla, A., Meco, G., Denefle, P., Agid, Y. & Brice, A. (1999). A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. Hum. Mol. Genet. 8, 567-574.
2. Agundez, J. A. G., Jimenezjimenez, K. J., Luengo, A., Bernal, M. L., Molina, J. A., Ayuso, L., Vazquez, A., Parra, J., Duarte, J., Coria, F., Ladero, J. M., Alvarez, J. C. & Benitez, J. (1995). Association Between the Oxidative Polymorphism and Early-Onset Of Parkinsons-Disease. Clin. Pharm. Therapeut. 57, 291-298.
3. Agundez, J. A. G., JimenezJimenez, F. J., Luengo, A., Molina, J. A., OrtiPareja, M., Vazquez, A., Ramos, F., Duarte, J., Coria, F., Ladero, J. M., AlvarezCermeno, J. C. & Benitez, J. (1998). Slow allotypic variants of the NAT2 gene and susceptibility to early-onset Parkinson's disease. Neurology 51, 1587-1592.
4. Armstrong, M., Daly, A. K., Cholerton, S., Bateman, D. N. & Idle, J. R. (1992). Mutant Debrisoquine Hydroxylation Genes In Parkinsons-Disease. Lancet 339, 1017-1018.
5. Baker, M., Litvan, I., Houlden, H., Adamson. J., Dickson, D., Perez-Tur, J., Hardy, J., Lynch, T., Bigio, E. & Hutton, M. (1999). Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum. Mol. Genet. 8, 711-715.
6. Bandmann, O., Davis, M. B., Marsden, C. D. & Harding, A. K. (1995). Sequence Of the Superoxide-Dismutase 1 (Sod 1) Gene In Familial Parkinsons-Disease. J. Neurol. Neurosurg. Psych. 59, 90-91.
7. Bandmann, O., Davis, M. B., Marsden, C. D. & Wood, N. W. (1990). The Human Homolog Of the Weaver Mouse Gene In Familial and Sporadic Parkinsons-Discase. Neuroscience. 72, 877-879.
8. Bandmann, O., Sweeney, M. G., Daniel, S. E., Marsden, C. D. & Wood, N. W. (1997a). Mitochondrial DNA polymorphisms in pathologically proven Parkinson's disease. Journal Of Neurology 244, 262-265.
9. Bandmann, O., Vaughan, J., Holmans, P., Marsden, C. D. & Wood, N. W. (1997b). Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease. Lancet 350, 1136-1139.
10. Barucha, N. E., Stokes, L., Schoenberg, B. S., Ward, G., Ince, S., Nutt, J. G., Eldridge, R., Calne, D. B., Mantel, N. & Duvoisin, R. (1980). A case-control study of twin pairs discordant for Parkinson's disease: a search for environmental risk factors. Neurology 36, 284-288.
11. Bell, J. I. & Lathrop, G. M. (1996). Multiple loci for multiple sclerosis [news; comment]. Nat. Genet. 13, 377-378.
12. Bon, M. A., Jansen Steur, E. N., De Vos. H. A. & Vermes, I. (1999). Neurogenetic correlates of Parkinson's disease: apolipoprotein-E and cytochrome P450 2D6 genetic polymorphism. Neurosci. Lett. 266, 149-151.
13. Bordet, R., Broly, F., Destee, A. & Libersa, C. (1994). Genetic-Polymorphism Of Cytochrome-P450 2d6 In Idiopathic Disease and Diffuse Lewy Body Disease. Clin. Neuropharn. 17, 484-488.
14. Burn, D. J., Mark, M. H., Playford, E. D., Maraganore. D. M., Zimmerman, T. R., Jr., Duvoisin, R. G., Harding, A. E., Marsden, C. D. & Brooks, D. J. (1992). Parkinson's disease in twins studied with 18F-dopa and positron emission tomography. Neurology 42, 1894-1900.
15. Carlsson, A. (1995). Towards a New Understanding Of Dopamine-Receptors. Clin. Neuropharm. 18, S 6-S 13.
16. Chen, R., Gosavi, N. S., Tan, L., Forno, L. S., Tanner, C. M., Langston, J. W. & Chan, P. (2000). Identification of a novel Parkin gene mutation associated with autosomal dominant familial Parkinsonism with Lewy bodies. Neurology 54 (suppl 3), A427.
17. Conrad, C., Andreadis, A., Trojanowski, J. Q., Dickson, D. W., Kang, D., Chen, X., Wiederholt, W., Hansen, L., Masliah, E., Thal, L. J., Katzman, R., Nia, Y. & Saitoh, T. (1997). Genetic Evidence for the involvement of Tau in Progressive Supranuclear Palsy. Ann. Neurol. 41, 277-281.
18. Conway, K. A., Harper, J. D. & Lansbury, P. T. (1998). Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat. Med. 4, 1318-1320.
19. De Michele, G., Filla, A., Volpe, G., Demarco, V., Goglicttino, A., Ambrosio, G., Marconi, R., Castellano, A. E. & Campanella. G. (1996). Environmental and Genetic Risk-Factors In Parkinsons-Disease - a Case-Control Study In Southern Italy. Morement Disord. 11, 17-23.
20. De Rijk, M., Tzourio, C. & Breteler, M. (1997). Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. J. Neurol. Neurosurg. Psych. 62, 10-15.
21. De Silva, H., Khan, N. & Wood, N. (2000). The genetics of Parkinson's disease. Curr. Op. Genet. Der. 10, 292-298.
22. Diederich, N., Hilger. G., Goetz, C. G., Keipes, M., Hentges, F., Vieregge, P. & Metz, H. (1996). Genetic-Variability Of the Cyp 2d6 Gene Is Not a Risk Factor For Sporadic Parkinsons-Disease. Ann. Neurol. 40, 463-465.
23. El-Agnaf, O. M., Jakes, R., Curran, M. D., Middleton, D., Ingenito, R., Bianchi, E., Pessi, A., Neill, D. & Wallace, A. (1998). Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments. FEBS Lett. 440, 71-75.
24. Elbaz, A., Grigoletto, F., Breteler, M. M., Baldereschi, M., Dartigues, J. F., LopezPousa, S., ManubesBertran, J. M., Alperovitch, A., Tzourio, C. & Rocca, W. A. (1998). Familial aggregation of Parkinson's disease: A population-based case-control study in Europe. Neurology 50, 600-602.
25. Engelender, S., Kaminsky, Z., Guo, X., Sharp, A. H., Amaravi, R. K., Kleiderlein, J., Margolis, R. L., Troncoso. J. C., Lanahan, A. A., Worley, P. F., Dawson, V. L., Dawson, T. M., Ross, C. A. (1999). Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions, Nat. Genet. 22, 110-114.
26. Farrer, L. A., O'Sullivan, D. M., Cupples, L. A., Growden, J. H. & Myers, R. H. (1989). Assessment of genetic risk for Alzheimer's disease among first degree relatives. Ann. Neurol. 25, 485-493.
27. Farrer, M., Gwinn-Hardy, K., Mutton, M., Hardy, J. (1999). The genetics of disorders with synuclein pathology and parkinsonism. Hum. Mol. Genet. 8, 1901-1905.
28. Farrer, M., Gwinn-Hardy, K., Muenter, M., DeVrieze, F. W., Crook, R., Perez-Tur, J., Lincoln, S., Maraganore, D., Adler, C., Newman, S., MacElwee, K., McCarthy, P., Miller, C., Waters, C. & Hardy, J. (1999). A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor. Hum. Mol. Genet. 8, 81-85.
29. Feany, M. B., Bender, W. W. (2000). A Drosophila model of Parkinson's disease. Nature 404, 394-398.
30. Gasser, T., Muller-Myhsok, B., Supala, A., Zimmer, E., Wieditz, G., Wszolek, Z. K., Vieregge, P., Bonifati, V. & Oertel, W. H. (1996). The Cyp2d6b Allele Is Not Overrepresented In a Population Of German Patients With Idiopathic Parkinsons-Disease. J. Neurol. Neurosurg. Psych. 61, 518-520.
31. Gasser, T., Muller-Myhsok, B., Wszolek, Z. K., Durr, A., Vaughan, J. R., Bonifati, V., Meco, G., Bereznai, B., Oehlmann, R., Agid, Y., Brice, A. & Wood, N. (1997). Genetic complexity and Parkinson's disease [letter: comment]. Science 277, 388-389.
32. Gasser, T., MullerMyhsok, B., Wszolek, Z. K., Oehlmann, R., Calne, D. B., Bonifati, V., Bereznai, B., Fabrizio, E., Vieregge, P. & Horstmann, R. D. (1998). A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat. Genet. 18, 262-265.
33. Gasser, T., Wszolek, Z. K., Trofatter, J., Ozelius, L., Uitti, R. J., Lee, C. S., Gusella, J., Pfeiffer, R. F., Calne, D. B. & Breakefield, X. O. (1994). Genetic-Linkage Studies In Autosomal-Dominant Parkinsonism - Evaluation Of 7 Candidate Genes. Ann. Neurol. 36, 387-396.
34. Giasson, B. I., Uryu, K., Trojanowski, J. Q. & Lee, V. M. (1999). Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro. J. Biol. Chem. 274, 7619-7622.
35. Goedert, M., Crowther, R. A., Spillantini, M. G. (1998). Tau mutations cause frontotemporal dementias. Neuron 21, 955-958.
36. Golbe, L., Di Iorio, G., Bonavita, V., Miller, D. & Duvoisin, R. (1990). A large kindred with autosomal dominant Parkinson's disease. Ann. Neurol. 27, 276-282.
37. Golbe, L. I. Diiorio, G., Sanges, G., Lazzarini, A. M., Lasala, S., Bonavita, V. & Duvoisin, R. C. (1996). Clinical Genetic-Analysis Of Parkinsons-Disease In the Contursi Kindred. Ann. Neurol. 40, 767-775.
38. Gunel, M., Awad, I. A., Finberg, K., Steinberg, G. K., Craig, H. D., Cepeda, O., Nelson-Williams, C. & Lifton, R. P. (1996). Genetic heterogeneity of inherited cerebral cavernous malformation. Neurosurgery 38, 1265-1271.
39. Harhangi, B. S., Farrer, M. J., Lincoln, S., Bonifati, V., Meco, G., De Michele, G., Brice, A., Durr, A., Martinez, M., Gasser, T., Bereznai, B., Vaughan, J. R., Wood. N. W., Hardy, J., Oostra, B. A. & Breteler, M. M. (1999). The He93Met mutation in the ubiquitin carboxy-terminal-hydrolase-L1 gene is not observed in European cases with familial Parkinson's disease. Neurosci. Lett. 270, 1-4.
40. Higuchi, S., Muramatsu, T., Arai, H., Hayashida, M., Sasaki, H. & Trojanowski, J. Q. (1995). Polymorphisms Of Dopamine-Receptor and Transporter Genes and Parkinsons-Disease. J. Neur. Transmiss, - Parkinsons Disease and Dementia Section 10, 107-113.
41. Ho, S., Kapadi, A., Ramsden, D. & Williams, A. (1995). An allelic association study of monoamine oxidase-B in Parkinson's disease. Ann. Neurol. 37, 403-405.
42. Ho, S. L., Kung, M. H. W., Li, L. S. W., Lauder, I. J. & Ramsden, D. B. (1999). Cytochrome P4502D6 (debrisoquine 4-hydroxylase) and Parkinson's disease in Chinese and Caucasians, Eur. J. Neurol. 6, 323-329.
43. Hotamisligil, G. S., Girmen, A. S., Fink, J. S., Tivol, E., Shalish, C., Trofatter, J., Baenziger, J., Diamond, S., Markham, C., Sullivan, J. & et al. (1994). Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease. Mov. Disord. 9, 305-310.
44. Hughes, A., Daniel, S., Kilford, L. & Lees, A. (1992). Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psych. 55, 181-184.
45. Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., PickeringBrown, S., Chakraverty, S., Isaacs, A., Grover, A., Hackett, J., Adamson, J., Lincoln, S., Dickson, D., Davies, P., Petersen, R. C., Stevens, M., deGraaff, E., Wauters, E., vanBaren, J., Hillebrand, M., Joosse, M., Kwon, J. M., Nowotny, P., Che, L. K., Norton, J., Morris, J. C., Reed, L. A., Trojanowski, J., Basun, H., Lannfelt, L., Neystat, M., Fahn, S., Dark, K., Tannenberg, T., Dodd, P. R., Hayward, N., Kwok, J. B. J., Schofield, P. R., Andreadis, A., Snowden, J., Craufurd, D., Neary, D., Owen, F., Oostra, B. A., Hardy, J., Goate, A., vanSwieten, J., Mann. D., Lynch, T. & Heutink, P. (1908). Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702-705.
46. Irwin, I., Langston, J. W. & DeLanney, L. R. (1987). 4-Phenylpyridine (4PP) and MPTP: the relationship between striatal MPP+ concentrations and neurotoxicity. Life Sciences 40, 731-740.
47. Ishikawa, T., Dhawan, V., Chaly, T., Robeson, W., Belakhlef, A., Mandel, F., Dahl, R., Marouleff, C. & Eidelberg, D. (1996). Fluorodopa Positron Emission Tomography With an Inhibitor Of Catechol-O-Methyl-transferase - Effect Of the Plasma 3-O-Methyldopa Fraction On Data-Analysis. J. Cereb. Blood Flou Metab. 16, 854-863.
48. Jensen, P. H., Nielsen, M. S., Jakes, R., Dotti, G. & Goedert, M. (1998). Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation, J. Biol. Chem. 273, 26292-20294.
49. Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y. & Shimizu, N. (1998). Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism [see comments]. Nature 392, 605-608.
50. Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel. S., Przuntek, H., Epplen, J. T., Schols, L. & Riess, O. (1998). Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease [letter]. Nat. Genet. 18, 106-108.
51. Kruger, R., Vieira-Saecker, A. M., Kuhn, W., Berg, D., Muller, T., Kuhnl, N., Fuchs, G. A., Storch, A., Hungs, M., Woitalla, D., Przuntek, H., Epplen, J. T., Schols, L. & Riess, O. (1999). Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/apolipoprotein E genotype. Ann. Neurol. 45, 611-617.
52. Kurth, J. H., Kurth, M. C., Poduslo, S. E. & Schwankhaus, J. D. (1993). Association Of a Monoamine Oxidase-B Allele With Parkinsons-Disease. Annals Of Neurology 33, 368-372.
53. Langston, J., Ballard, P., Tetrud, J. & Irwin, I. (1983). Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979-980.
54. Lazzarini, A. M., Myers, R. H., Zimmerman, T. R., Jr., Mark, M. H., Golbe, L. I., Sage, J. I., Johnson, W. G. & Duvoisin, R. C. (1994). A clinical genetic study of Parkinson's disease: evidence for dominant transmission. Neurology 44, 499-506.
55. Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M. J., Jonnalagada, S., Chernova, T., Dehejia, A., Lavedan, C., Gasser, T., Steinbach, P. J., Wilkinson, K. D. & Polymeropoulos, M. H. (1998). The ubiquitin pathway in Parkinson's disease. Nature 395, 451-452.
56. Lincoln, S., Vaughan, J., Wood, N., Baker, M., Adamson, J., Gwinn-Hardy, K., Lynch, T., Hardy, J. & Farrer, M. (1999). Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's disease. Neuroreport 10, 427-429.
57. Luecking, C. B., Durr, A., Bonifati, V. & Vaughan, J. (2000). Association between early-onset Parkinson's disease and mutations in the parkin gene. N. Engl. J. Med. 342, 1545-1620.
58. Maraganore, D. M. (2000). Case-Control Study of Debrisoquine 4-Hydroxylase, N-Acetyltransferase2 and Apolipoprotein E Gene Polymorphisms in Parkinson's Disease. Mov. Disord. 15, 714-719.
59. Maraganore, D. M., Farrer, M. J., Hardy, J. A., Lincoln, S. J., McDonnell, S. K. & Rocca, W. A. (1999). Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease. Neurology 53, 1858-1860.
60. Marder, K., Tang, M. X., Mejia, H., Alfaro, B., Cote, L., Louis, K., Groves, J. & Mayeux, R. (1996). Risk Of Parkinsons-Disease Among First-Degree Relatives a Community-Rased Study. Neurology 47, 155-160.
61. Marsden, C. D. (1987). Parkinson's disease in twins [letter]. J. Neurol. Neurosurg. Psych. 50, 105-106.
62. Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A. & Mucke, L. (2000). Dopaminergic loss and inclusion body formation in alpha-synuclein mice: Implications for neurodegenerative disorders. Science 287, 1265-1269.
63. Matsumine, H., Saito, M., Shimoda-Matsubayashi. S., Tanaka. H., Ishikawa, A., Nakagawa-Hattori, Y., Yokochi, M., Kobayashi, T., Igarashi, S., Takano, H., Sanpei, K., Koike, R., Mori, H., Kondo, T., Mizutani, Y., Schaffer, A. A., Yamamura, Y., Nakamura, S., Kuzuhara, S., Tsuji, S. & Mizuno, Y. (1997). Localization of a gene for an autosomal recessive form of juvenile Parkinsonism to chromosome 6q25.2-27. Am. J. Hum. Genet. 60, 588-596.
64. Mellick, G. D., Buchanan, D. D., McCann, S. J., James, K. M., Johnson, A. G., Davis. D. R., Liyou, N., Chan, D. & LeCouteur, D. G. (1999). Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease. Mov. Disord. 14, 219-224.
65. Mellick, G. D. & Silburn, P. A. (2000). The ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism does not confer protection against idiopathic Parkinson's disease. Neurosci. Lett. 293, 127-130.
66. Morens, D. M., Grandinetti, A., Reed, D. & White, L. R. (1994). Smoking associated protection from Alzheimer's and Parkinson's disease. Lancet 343, 356-357.
67. Mori, H., Kondo, T. & Yokochi, M. (1998). Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q. Neuroloyy 51, 890-892.
68. Narhi, L., Wood, S. J., Steavenson, S., Jiang, Y., Wu, G. M., Anafi. D., Kaufman, S. A., Martin, F., Sitney, K., Denis, P., Louis, J. C., Wypyeh, J., Biere, A. L. & Citron, M. (1999). Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation [published erratum appears in J. Biol. Chem. 274. 13728]. J. Biol. Chen. 274. 9843-9846.
69. Narhi, L., Wood, S. J., Steavenson, S., Jiang, Y., Wu, G. M., Anafi. D., Kaufman, S. A., Martin, F., Sitney, K., Denis, P., Louis, J. C., Wypyeh, J., Biere, A. L. & Citron, M. (1999). Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation [published erratum appears in J. Biol. Chem. 274. 13728]. J. Biol. Chen. 274. 9843-9846.
70. Nicholl, D., Bennett, P., Hiller, L., Bonifati, V., Vanacore, N., Fabbrini, G., Marconi, R., Colosimo, C., Lamberti, P., Stocchi, F., Bonuccelli, U., Vieregge, P., Ramsden, D., Meco, G. & Williams, A. (1999). A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism. Neurology 53, 1382-1383.
71. Pakkenberg, B., Moller, A., Gundersen, H. J., Mouritzen Dam, A., Pakkenberg, H. (1991). The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method. J. Neurol. Neurosurg. Psych. 54, 30-33.
72. Papp, M. I. Kahn, J. E., Lantos, P. L. (1989). Glial Cytoplasmic Inclusions In the CNS Of Patients With Multiple System Atrophy (Striatonigral Degeneration. Olivopontocerebellar Atrophy and Shy-Drager Syndrome). J. Neurol. Sci. 94, 79-100.
73. Parboosingh, J. S., Rousseau, M., Rogan, F., Amit, Z., Chertkow, H., Johnson, W. G., Manganaro, F., Schipper, H. N., Curran, T. J., Stoessl, J. & Rouleau, G. (1995). Absence Of Mutations In Superoxide-Dismutase and Catalase Genes In Patients With Parkinsons-Disease. Arch. Neurol. 52, 1160-1163.
74. Parker, W. D., Boyson, S. J. & Parks, J. K. (1989). Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann. Neurol. 26, 719-723.
75. Parkinson, J. (1817). An Essay on the Shaking Palsy. Sherwood, Neely. and Jones. London.
76. Pastor, P., Ezquerra, M., Munoz, E., Marti, M. J., Blesa, R., Tolosa, E. & Oliva, R. (2000). Significant association between the tau gene A0/A0 genotype and Parkinson's disease. Ann. Neurol. 47, 242-245.
77. Patil, N., Cox, D. R., Bhat, D., Faham, M., Myers, R. M. & Peterson, A. S. (1995). A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation [see comments]. Nat.Genet. 11, 126-129.
78. Payami, H., Larsen, K., Bernard, S. & Nutt, J. (1994). Increased Risk Of Parkinsons-Disease In Parents and Siblings Of Patients. Ann. Neurol. 36, 659-661.
79. Piccini, P., Burn, D. J., Ceravolo, R., Maraganore, D. & Brooks, D. J. (1999). The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins. Ann. Neurol. 45, 577-582.
80. Piccini, P., Morrish, P. K., Turjanski, N., Sawle, G. V., Burn, D. J., Weeks, R. A., Mark, M. H., Maraganore, D. M., Lees, A. J. & Brooks, D. J. (1997). Dopaminergic function in familial Parkinson's disease: a clinical and 18F-dopa positron emission tomography study. Ann. Neurol. 41, 222-229.
81. Plante-Bordeneuve, V., Davis. M. B., Maraganore, D. M., Marsden, C. D. & Harding, A. E. (1994). Tyrosine-Hydroxylase Polymorphism In Familial and Sporadic Parkinsons-Disease. Mov. Disord. 9, 337-339.
82. Plante-Bordeneuve, V., Taussig, D., Thomas, F., Said, G., Wood, N. W., Marsden, C. D. & Harding, A. E. (1997). Evaluation of four candidate genes encoding proteins of the dopamine pathway in familial and sporadic Parkinson's disease: evidence for association of a DRD2 allele. Neurology 48, 1589-1593.
83. Polymeropoulos, M. H., Higgins, J. J., Golbe, L. I., Johnson, W. G., Ide, S. E., Di Iorio, G., Sanges, G., Stenroos, E. S., Pho, L. T., Schaffer, A. A., Lazzarini, A. M., Nussbaum, R. L. & Duvoisin, R. C. (1996). Mapping of a gene for Parkinson's disease to chromosome 4q21-q23 [see comments]. Science. 274, 1197-1199.
84. Polymeroulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E. S., Chandrasekharappa, S., Athanassiadou, A., Papapetropoulos, T., Johnson, W. G., Lazzarini, A. M., Duvoisin, R. C., DiIorio, G., Golbe, L. I. & Nussbaum, R. L. (1997). Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047.
85. Quinn, N. P. (1989). Multiple System Atrophy - the Nature Of the Beast. J. Neurol. Neurosurg. Psych. S 78-89.
86. Riedl, A. G., Watts, P. M., Jenner, P. &Marsden, C. D. (1998). P450 enzymes and Parkinson's disease: the story so far. Mov. Disord. 13, 212-220.
87. Roses, A. D. & Strittmatter, W. J. (1996). Apolipoprotein E and Alzheimer's Disease. Ann. Rev. Neurosci. 19, 53-77.
88. Rybicki, B. A., Johnson, C. C., Peterson, E. L., Kortsha, G. X. & Gorell, J. M. (1999). A family history of Parkinson's disease and its effect on other PD risk factors. Neuroepiden. 18, 270-278.
89. Sabbagh, N., Brice, A., Marez, D., Durr, A., Legrand, M., LoGuidice, J. M., Destee, A., Agid, Y. & Broly, F. (1999). CYP2D6 polymorphism and Parkinson's disease susceptibility. Mov. Disord. 14, 230-236.
90. Schapira, A. H. V., Holt, I. J., Sweeney, M., Harding, A. E., Jenner, P. & Marsden, C. D. (1990). Mitochondrial DNA analysis in Parkinson's disease. Mov. Disord. 5, 294-297.
91. Schrag, A., Ben-Shlomo, Y., Quinn, N. P. (1999). Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet 354, 1771-1775.
92. Sergeant, N., Wattez, A. & Delacourte, A. (1999). Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: Tau pathologies with exclusively 'exon 10' isoforms. J. Neurochem. 72, 1243-1249.
93. Shimura, H., Hattori, N., Kubo, S., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K. & Suzuki, T. (2000). Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet. 25, 302-305.
94. Shimura, H., Hattori, N., Kubo, S., Yoshikawa, M., Kitada, T., Matsumine, H., Asakawa, S., Minoshima, S., Yamamura, Y., Shimizu, N. & Mizuno, Y. (1999). Immunohistochemical and subcellular localization of parkin protein: Absence of protein in autosomal recessive juvenile parkinsonism patients. Ann. Neurol. 45, 668-672.
95. Spellman, G. (1962). Report of familial cases of parkinsonism: evidence of a dominant trait in a patient's family. JAMA 179, 372-374.
96. Spielman, R. S. & Ewens, W. J. (1998). A sibship test for linkage in the presence of association: the sib transmission/disequilibrium test [see comments]. Am. J. Hum. Genet. 62, 450-458.
97. Spillantini, M. G., Bird, T. D. & Ghetti, B. (1998). Frontotemporal dementia and Parkinsonism linked to chromosome 17: a new group of tauopathies. Brain Pathol. 8, 387-402.
98. Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R. & Goedert, M. (1997). Alpha-synuclein in Lewy bodies. Nature 388, 839-840.
99. Stroombergen, M. C. M. J., Waring, R. H., Bennett, P. & Williams, A. C. (1996). Determination of the GSTMt gene deletion frequency in Parkinson's disease by allele specific PCR. Parkinsonism & Related Disord. 2, 151-154.
100. Sunada, Y., Saito, F. & Matsunnira, K. (1998). Differential expression of the parkin gene in the human brain and peripheral leukocytes. Neurosci. Lett. 254, 180-182.
101. Supala, A., Wszolek, Z. K. & Trofatter, J. (1994). Genetic linkage studies in autosomal dominant parkinsonisin: evaluation of candidate genes. Mov. Disord. 9, 32.
102. Swerdlow, R. H., Parks, J. K., Miller, S. W., Tuttle, J. B., Trimmer, P. A., Sheehan, J. P., Bennett, J. P., Davis, R. E. & Parker, W. D. (1996). Origin and Functional Consequences Of the Complex-I Defect In Parkinsons-Disease. Ann. Neurol. 40, 663-671.
103. Tabrizi, S. J., Orth, M., Wilkinson, J. M., Taanman, J. W., Warner, T. T., Cooper, J. M., Schapira, A. H. (2000). Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity. Hum. Mol. Genet. 9, 2683-2689.
104. Tan, E. K., Khajavi, M., Thornby, J. I., Nagamitsu, S., Jankovic, J., Ashizawa, T. (2000). Variability and validity of polymorphism association studies in Parkinson's disease. Neurology. 55, 533-538.
105. Tanner, C. M. (1992). Epidemiology of Parkinson's disease. Neurologic Clinics 10, 317-329.
106. Tanner, C. M., Ottman, R.m Goldman, S. M., Ellenberg, J., Chan, P., Mayeux, R. & Langston, W. J. (1999). Parkinson's disease in twins: An etiologic study. JAMA 281, 341-346.
107. Tsuneoka, Y., Matsuo, Y., Iwahashi, K., Takeuchi, H. & Ichikawa, Y. (1993). A novel cytochrome P-450IID6 mutant gene associated with Parkinson's disease. J. Biochem. 114, 263-266.
108. Tu, P. H., Galvin, J. E., Baba, M., Giasson, B., Tomita, T., Leight, S., Nakajo, S., Iwatsubo, T., Trojanowski, J. Q. & Lee, V. M. Y. (1998). Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein. Ann. Neurol. 44, 415-422.
109. Ueda, K., Fukushirma, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D. A., Kondo, J., Ihara, Y. & Saitoh, T. (1993). Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc.Natl. Acad. Sci.USA 90, 11282-11286.
110. Vaughan, J., Durr, A., Tassin, J., Bereznai, B., Gasser, T., Bonifati, V., DeMichele, G., Fabrizio, E., Volpe, G., Bandmann, O., Johnson, W. G., Golbe, L. I., Breteler, M., Meco, G., Agid, Y., Brice, A., Marsden, C. D. & Wood, N. W. (1998a). The alpha-synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: A study of 230 European cases. Ann. Neurol. 44, 270-273.
111. Vaughan, J. R., Farrer, M., De Michele, G., Volpe, G., Hardy, J. & Wood, N. W. (1999). Further evidence for a chromosome 4p haplotype segregating with Parkinson's disease in an independent Italian Kindred. Am.J. Hum. Genet. 65, A496.
112. Vaughan, J. R., Farrer, M. J., Wszolek, Z. K., Gasser, T., Durr, A., Agid, Y., Bonifati, V., DeMichele, G., Volpe, G., Lincoln, S., Breteler, M., Meco, G., Brice, A., Marsden, C. D., Hardy, J. & Wood, N. W. (1998b). Sequencing of the alpha-synuclein gene in a large series of cases of familial Parkinson's disease fails to reveal any further mutations. The European Consortium on Genetic Susceptibility in Parkinson's Disease (GSPD). Hum. Mol. Genet. 7, 751-753.
113. Vieregge, P., Schiffke, K. A., Friedrich, H. J., Muller, B. & Ludin, H. P. (1992). Parkinsons-Disease In Twins. Neurology 42, 1453-1461.
114. Wakabayashi, K., Engelender, S., Yoshimoto, M., Tsuji, S., Ross, C. A., Takahashi, H. (2000). Synphilin-1 is present in Lewy bodies in Parkinson's disease. Ann. Neurol. 47, 521-523.
115. Ward, C., Duvoisin, R., Ince, S., Nutt, J., Eldridge, R. & Calne, D. (1983). Parkinson's disease in 65 pairs of twins and in a set of quadruplets. Neurology 33, 815-824.
116. Wenning, G. K., Tison, F., BenShlomo, Y., Daniel, S. E., Quinn, N. P. (1997). Multiple system atrophy: A review of 203 pathologically proven cases. Mov. Disord. 12, 133-147.
117. Wintermeyer, P., Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Berg, D., Becker, G., Leroy, E., Polymeropoulos, M., Berger, K., Przuntek, H., Schols, L., Epplen, J. & Riess. O. (2000). Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients. Neuroreport 11, 2079-2082.
118. Wood, N. (1997). Genetic aspects of parkinsonism. Baillieres Clin. Neurol. 6, 37-53.
119. Wszolek, Z. K., Pfeiffer, B., Fulgham, J. R., Parisi, J. E., Thompson, B. M., Uitti, R. J., Calne, D. B. & Pfeiffer, R. F. (1995). Western Nebraska Family (Family-D) With Autosomal-Dominant Parkinsonism. Neurology 45, 502-505.
120. Zhang, Z. X. & Roman, G. C. (1993). Worldwide occurrence of Parkinson's disease: an updated review. Neuroepidem. 12, 195-208.